BTCY Stock Overview
Biotricity, Inc., a medical technology company, provides biometric data monitoring solutions in the United States.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 1/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Biotricity, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$1.25 |
| 52 Week High | US$4.37 |
| 52 Week Low | US$0.70 |
| Beta | 1.54 |
| 1 Month Change | -6.02% |
| 3 Month Change | 39.90% |
| 1 Year Change | -66.53% |
| 3 Year Change | -90.74% |
| 5 Year Change | -74.59% |
| Change since IPO | -92.14% |
Recent News & Updates
Recent updates
Investors Give Biotricity, Inc. (NASDAQ:BTCY) Shares A 38% Hiding
Jan 26
Many Still Looking Away From Biotricity, Inc. (NASDAQ:BTCY)
Oct 26Biotricity GAAP EPS of -$0.09, revenue of $2.06M
Aug 15Biotricity, Inc.: A First Take
Jul 28Is Biotricity (NASDAQ:BTCY) Using Debt In A Risky Way?
Apr 09Does Biotricity (NASDAQ:BTCY) Have A Healthy Balance Sheet?
Dec 11Biotricity: Capital Raise Leads To Buying Opportunity
Aug 31Shareholder Returns
| BTCY | US Healthcare Services | US Market | |
|---|---|---|---|
| 7D | -2.3% | 0.8% | 0.3% |
| 1Y | -66.5% | -6.5% | 24.2% |
Return vs Industry: BTCY underperformed the US Healthcare Services industry which returned -6.5% over the past year.
Return vs Market: BTCY underperformed the US Market which returned 24.2% over the past year.
Price Volatility
| BTCY volatility | |
|---|---|
| BTCY Average Weekly Movement | 19.6% |
| Healthcare Services Industry Average Movement | 9.9% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in US Market | 16.6% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: BTCY's share price has been volatile over the past 3 months.
Volatility Over Time: BTCY's weekly volatility has increased from 14% to 19% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 55 | Waqaas Al-Siddiq | www.biotricity.com |
Biotricity, Inc., a medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It offers Bioflux mobile cardiac telemetry solution, an integrated ECG device; and ECG analysis software that analyzes and synthesizes patient ECG monitoring data, as well as software components.
Biotricity, Inc. Fundamentals Summary
| BTCY fundamental statistics | |
|---|---|
| Market cap | US$12.33m |
| Earnings (TTM) | -US$15.39m |
| Revenue (TTM) | US$11.63m |
1.0x
P/S Ratio-0.8x
P/E RatioIs BTCY overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BTCY income statement (TTM) | |
|---|---|
| Revenue | US$11.63m |
| Cost of Revenue | US$4.01m |
| Gross Profit | US$7.62m |
| Other Expenses | US$23.00m |
| Earnings | -US$15.39m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -1.62 |
| Gross Margin | 65.52% |
| Net Profit Margin | -132.33% |
| Debt/Equity Ratio | -82.6% |
How did BTCY perform over the long term?
See historical performance and comparison